SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000912057-20-000078
Filing Date
2020-02-14
Accepted
2020-02-14 16:15:53
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2084641
2 g52075.jpg GRAPHIC 35182
3 g67368.jpg GRAPHIC 20566
4 g90497.jpg GRAPHIC 66704
5 g128640.jpg GRAPHIC 30383
6 g164461.jpg GRAPHIC 11131
7 g303045.jpg GRAPHIC 71183
8 g316093.jpg GRAPHIC 47549
9 g412503.jpg GRAPHIC 59607
10 g621163.jpg GRAPHIC 159440
11 g708735.jpg GRAPHIC 18418
12 g866638.jpg GRAPHIC 29580
13 g926108.jpg GRAPHIC 53460
14 g938891.jpg GRAPHIC 48137
15 g976574.jpg GRAPHIC 49787
16 g982218.jpg GRAPHIC 22604
  Complete submission text file 0000912057-20-000078.txt   3084222
Mailing Address 456 MONTGOMERY STREET SUITE 1200 SAN FRANCISCO CA 94104
Business Address 456 MONTGOMERY STREET SUITE 1200 SAN FRANCISCO CA 94104 (415) 655-4899
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03054 | Film No.: 20620061
SIC: 2834 Pharmaceutical Preparations